BioCentury | Mar 22, 2010
Company News

Byron Biopharma, Cel-Sci deal

...Multikine to treat head and neck cancer in mid-2010. Multikine is a combination of cytokines. Byron Biopharma LLC...
Items per page:
1 - 1 of 1
BioCentury | Mar 22, 2010
Company News

Byron Biopharma, Cel-Sci deal

...Multikine to treat head and neck cancer in mid-2010. Multikine is a combination of cytokines. Byron Biopharma LLC...
Items per page:
1 - 1 of 1